To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
United States118e CongrèsHR-383House of Representatives
Mis à jour : 27 janv. 2023
Résumé
Aucun résumé n’est disponible.
Textes du projet de loi
Tous les dossiers disponibles sont affichés.
Chronologie
Referred to the House Committee on Energy and Commerce.
House of Representatives
Introduced in House
Referred to the Subcommittee on Health.
House of Representatives
Tous les dossiers disponibles sont affichés.